GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (ASX:TRI) » Definitions » Other Operating Expense

TrivarX (ASX:TRI) Other Operating Expense : A$1.52 Mil (TTM As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is TrivarX Other Operating Expense?

TrivarX's Other Operating Expense for the six months ended in Dec. 2023 was A$0.74 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$1.52 Mil.

TrivarX's quarterly Other Operating Expense declined from Dec. 2022 (A$0.83 Mil) to Jun. 2023 (A$0.78 Mil) and declined from Jun. 2023 (A$0.78 Mil) to Dec. 2023 (A$0.74 Mil).

TrivarX's annual Other Operating Expense increased from Jun. 2021 (A$0.94 Mil) to Jun. 2022 (A$1.80 Mil) but then declined from Jun. 2022 (A$1.80 Mil) to Jun. 2023 (A$1.61 Mil).


TrivarX Other Operating Expense Historical Data

The historical data trend for TrivarX's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX Other Operating Expense Chart

TrivarX Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.86 1.55 0.94 1.80 1.61

TrivarX Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.05 0.75 0.83 0.78 0.74

TrivarX Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$1.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TrivarX Other Operating Expense Related Terms

Thank you for viewing the detailed overview of TrivarX's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


TrivarX (ASX:TRI) Business Description

Traded in Other Exchanges
Address
647 Beaufort Street, Mount Lawley, WA, AUS, 6050
TrivarX Ltd Formerly Medibio Ltd is a medical technology company. The principal activity of the company is conducting clinical research, product development, and early-stage commercialization of mental health technology using objective biomarkers to assist in the screening, diagnosing monitoring, and management of depression and other mental health conditions. It serves both consumer and healthcare provider markets. In addition, the company offers various psychological services to customers in Australia. The company operates in two geographical markets; Australia and the United States. The company has one operating segment, being the research, development, and commercialization of its Software as a Service product.